Augmedix, Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2019 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Augmedix, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2019 to Q4 2023.
  • Augmedix, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $50.6M, a 13.8% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $50.6M +$6.14M +13.8% Dec 31, 2023 10-K 2024-03-26
Q4 2022 $44.5M +$7.91M +21.6% Dec 31, 2022 10-K 2024-03-26
Q4 2021 $36.5M +$5.7M +18.5% Dec 31, 2021 10-K 2022-03-30
Q4 2020 $30.9M +$3.71M +13.7% Dec 31, 2020 10-K 2022-03-30
Q4 2019 $27.1M Dec 31, 2019 10-K/A 2021-06-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.